Analysis of Changes in Medication Prescriptions After Hospitalization for 4 Disciplines: Gerontology, Diabetology, Cardiology and Rheumatology: Medical, Pharmaceutical and Economic Aspects (PHMEV)

Public Assistance-Hospitals of Marseille (AP-HM)

Status: Unknown

Conditions: Diabetes; Cardiac Disease; Rheumatic Diseases

Treatments: Other: collection of prescription data

Study type: Observational

Funder types: Other

Identifiers

NCT03371303

2016-25

Details and patient eligibility

About

The modifications of the medicinal treatments secondary to the hospitalizations have multiple reasons: reassessment of the previous treatment (conciliation), new therapeutic necessities, potential risk of iatrogeny or of drug interaction, restrictions of the therapeutic booklet, classification in reserve or hospital prescription ... These modifications are potentially generating extra costs for the Health Insurance and are monitored under the terms of the Contract of Good Use. The aims of this analysis are to define the medical-pharmaceutical rationale of the treatment changes imposed by hospitalization in a university-hospital center, their influence on the security of the medical treatment of patients and their financial implications for healthcare organizations

Enrollment: 400 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

inclusion criteria

• Patient social insured
• Patient belonging to the general social security scheme
• Patient followed in cardiology, rheumatology, geriatrics or diabetology departments

no exclusion criteria

Trial design

400 participants in 4 patient groups

diabetology

Treatment:

Other: collection of prescription data

cardiology

Treatment:

Other: collection of prescription data

rheumatology

Treatment:

Other: collection of prescription data

geriatrics

Treatment:

Other: collection of prescription data